172 related articles for article (PubMed ID: 397061)
1. Empirical therapy in febrile granulocytopenic patients.
Gaya H
Eur J Cancer (1965); 1979; 15 Suppl():51-8. PubMed ID: 397061
[No Abstract] [Full Text] [Related]
2. Rational basis for the choice of regimens for empirical therapy of sepsis in granulocytopenic patients. A report of the EORTC International Antimicrobial Therapy Project Group.
Gaya H
Schweiz Med Wochenschr Suppl; 1983; 14():49-57. PubMed ID: 6361992
[TBL] [Abstract][Full Text] [Related]
3. Combinations of antibiotics for therapy of severe infections in cancer patients.
Klastersky J
Eur J Cancer (1965); 1979; 15 Suppl():3-13. PubMed ID: 232443
[No Abstract] [Full Text] [Related]
4. Piperacillin plus amikacin therapy v carbenicillin plus amikacin therapy in febrile, granulocytopenic patients.
Winston DJ; Ho WG; Young LS; Hewitt WL; Gale RP
Arch Intern Med; 1982 Sep; 142(9):1663-7. PubMed ID: 6214228
[TBL] [Abstract][Full Text] [Related]
5. Empiric antibiotic therapy with an amikacin-carbenicillin-cefoxitin combination in granulocytopenic febrile patients--a clinical report.
Fernández-Rañada J; Fernández-Garese D; Caretti D; Vázquez L; Escudero A; Olmeda F
Int J Clin Pharmacol Ther Toxicol; 1983 Oct; 21(10):511-3. PubMed ID: 6642788
[TBL] [Abstract][Full Text] [Related]
6. Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer. The EORTC international antimicrobial therapy project group.
Schimpff SC; Gaya H; Klastersky J; Tattersall MH; Zinner SH
J Infect Dis; 1978 Jan; 137(1):14-29. PubMed ID: 624850
[No Abstract] [Full Text] [Related]
7. Rational basis for the choice of regimens for empirical therapy of sepsis in granulocytopenic patients.
Gaya H
Clin Haematol; 1984 Oct; 13(3):573-86. PubMed ID: 6388933
[TBL] [Abstract][Full Text] [Related]
8. Empiric therapy of febrile granulocytopenic patients.
Hopefl AW
Am J Hosp Pharm; 1979 Feb; 36(2):178-87. PubMed ID: 369364
[TBL] [Abstract][Full Text] [Related]
9. Empiric treatment of infections in granulocytopenic patients with acute leukemia: a study on amikacin-carbenicillin-cotrimoxazole.
Cortelezzi A; Radaelli F; Penagini R; Pogliani EM
Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):520-3. PubMed ID: 6983502
[TBL] [Abstract][Full Text] [Related]
10. A double beta-lactam combination versus an aminoglycoside-containing regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients.
De Jongh CA; Joshi JH; Thompson BW; Newman KA; Finley RS; Moody MR; Salvatore PC; Tenney JH; Drusano GL; Schimpff SC
Am J Med; 1986 May; 80(5C):101-11. PubMed ID: 3521269
[TBL] [Abstract][Full Text] [Related]
11. Management of infections in immunocompromised cancer patients.
Bajetta E; Gasparini G; Monfardini S; Volonterio A; Buzzoni R; Shinde S
Haematologica; 1984; 69(5):576-97. PubMed ID: 6437936
[No Abstract] [Full Text] [Related]
12. [Cefmenoxime or piperacillin plus amikacin. A prospective randomized comparison of empiric antibiotic therapy of febrile granulocytopenic cancer patients].
Sampi K; Kumai R; Maseki N; Sakurai M; Kaneko Y; Hattori M
Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):674-9. PubMed ID: 3469935
[TBL] [Abstract][Full Text] [Related]
13. Early results of a comparative trial of ceftazidime versus cephalothin, carbenicillin and gentamicin in the treatment of febrile granulocytopenic patients.
Ramphal R; Kramer BS; Rand KH; Weiner RS; Shands JW
J Antimicrob Chemother; 1983 Jul; 12 Suppl A():81-8. PubMed ID: 6352659
[TBL] [Abstract][Full Text] [Related]
14. Treatment of febrile granuloycytopenic cancer patients receiving antineoplastic therapy with a combination of carbenicillin, cefazolin and gentamicin.
Halpern J; Catane R; Sacks T; Fuks Z
J Med; 1983; 14(3):193-202. PubMed ID: 6580369
[TBL] [Abstract][Full Text] [Related]
15. Vancomycin added to empirical combination antibiotic therapy for fever in granulocytopenic cancer patients. European Organization for Research and Treatment of Cancer (EORTC) International Antimicrobial Therapy Cooperative Group and the National Cancer Institute of Canada-Clinical Trials Group.
J Infect Dis; 1991 May; 163(5):951-8. PubMed ID: 2019772
[TBL] [Abstract][Full Text] [Related]
16. Duration of empiric antibiotic therapy in granulocytopenic patients with cancer.
Pizzo PA; Robichaud KJ; Gill FA; Witebsky FG; Levine AS; Deisseroth AB; Glaubiger DL; Maclowry JD; Magrath IT; Poplack DG; Simon RM
Am J Med; 1979 Aug; 67(2):194-200. PubMed ID: 380336
[No Abstract] [Full Text] [Related]
17. Carbenicillin, cefazolin, and amikacin as an empiric therapy for febrile granulocytopenic cancer patients.
Klastersky J; Debusscher L; Weerts-Ruhl D; Prevost JM
Cancer Treat Rep; 1977 Nov; 61(8):1433-9. PubMed ID: 922748
[No Abstract] [Full Text] [Related]
18. Protocol for an international prospective trial of initial therapy regimens in neutropenic patients with malignant disease.
Gaya H; Klastersky J; Schimpff SC; Tattersall MH
Eur J Cancer (1965); 1975 Aug; 11suppl():1-4. PubMed ID: 767118
[No Abstract] [Full Text] [Related]
19. The management of febrile episodes in-neutropenic cancer.
Bishop JF; McLennan R; Whiteside MG
Med J Aust; 1977 Apr; 1(14):473-5. PubMed ID: 865367
[TBL] [Abstract][Full Text] [Related]
20. [Empiric therapy with piperacillin plus amikacin in febrile granulocytopenic patients with acute leukemia].
Sampi K; Kumai R; Maseki N; Sakurai M; Kaneko Y; Hattori M
Rinsho Ketsueki; 1986 Nov; 27(11):2065-9. PubMed ID: 3469434
[No Abstract] [Full Text] [Related]
[Next] [New Search]
